Suzan SAÇAR, Hüseyin TURGUT, Derya Hırçın CENGER, Erdal COŞKUN, ALİ ASAN, İlknur KALELİ

Post travmatik çoklu ilaç dirençli acinetobacter baumannii menenjitli olguda yüksek doz meropenem ile başarılı tedavi

Acinetobacter spp. birçok antimikrobiyal ajana karşı direnç geliştirerek tedavisi ve kontrolü güç olan infeksiyonlara neden olmaktadır. Bu çalışmada kafa travması sonrası çoklu ilaç dirençli Acinetobacter baumannii menenjiti gelişen olgunun klinik seyri ve tedavi sonucu bildirilmektedir. Yüksek doz meropenemle etkin tedaviye dikkat çekilmiştir.

Successful treatment of post travmatic multidrug-resistant acinetobacter baumannii menengitis with high dose meropenem

It is difficult to control and treat infections caused by Acinetobacter spp. due to its ability to develop resistance to many antimicrobial agents. Our case represented the clinical progress and results of the treatment of post traumatic multidrug-resistant Acinetobacter baumannii menengitis. An attention was attracted on the effective treatment wıth hıgh dose meropenem.

PDF

___

1. Jellison TK, McKinnon PS, Rybak MJ. Epidemiology, resistance, and outcomes of Acinetobacter baumannii bacteremia treated with imipenem-cilastatin or ampicillin-sulbactam. Pharmacotherapy 2001;21:142-148.
2. Allen DM, Hartman BJ: Acinetobacter species. In Mandel GL, Bennet JE, Dolin R (eds). Principles and Practice of Infectious Diseases. 5th ed. Philadelphia, Churchill Livingstone; 2000. p.2339-2344.
3. Forster D, Daschner FD. Acinetobacter species as nosocomial pathogens. Eur J Clin Microbiol Infect Dis 1998;17:73-77.
4. Özgenç O: Hastane kökenli çoklu dirençli gram negatif çomaklarda tedavi seçenekleri. XXXI. Türk Mikrobiyoloji Kongresi Kitabı, Antalya; 2004. p. 98-103.
5. Çakır N: Karbapenemler. In Leblebicioğlu H, Usluer G, Ulusoy S (eds). Güncel Bilgiler Işığında Antibiyotikler. Bilimsel Tıp Yayınevi, Ankara; 2003. p. 275-286.
6. Wood GC, Hanes SD, Croce MA, Fabian TC, Boucher BA. Comparison of ampicillin-sulbactam and imipenemcilastatin for the treatment of acinetobacter ventilatorassociated pneumonia. Clin Infect Dis 2002;34:1425-1430.
7. Cisneros JM, Rodriguez-Bano J. Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. Clin Microbiol Infect 2002;8:687-693.
8. Naradzay JFX, Browne BJ, Rolnick MA, Doherty RJ. Cerebral ventricular shunts. J Emerg Med 1999;17:311-322.
9. Çelik İ, Erol FS, Cihangiroğlu M, Akdemir İ, Tiftikçi M. Ventriküloperitoneal şant infeksiyonlu olguların değerlendirilmesi. ANKEM Dergisi 2003;17:60-64.
10. Theaker C, Azadian B, Soni N. The impact of Acinetobacter baumannii in the intensive care unit. Anaesthesia 2003;58:271-274.
11. Jang TN, Wang FD, Wang LS, Yu KW, Liu CY. Gramnegative bacillary meningitis in adults: a recent six year experience. J Formos Med Assoc 1993;92:540-546.
12. Hsueh PR, Teng LJ, Chen CY, Chen WH, Yu CJ, Ho SW et al. Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a University Hospital, Taiwan. Emerg Infect Dis 2002;8:827-832.
13. Cawley MJ, Suh C, Lee S, Ackerman BH. Nontraditional dosing of ampicillin-sulbactam for multidrug-resistant Acinetobacter baumannii meningitis. Pharmacotherapy 2002;22:527-532.
14. Yaman A, Taşova Y, Kibar F, Inal AS, Saltoglu N, Büyükçelik O et al. Investigation of the antibiotic susceptibility patterns of pathogens causing nosocomial infections. Saudi Med J 2004;25:1403-1409.
15. Eljamel MS, Foy PM. Acute traumatic CSF fistulae: the risk of intracranial infection. Br J Neurosurg 1990;4:369-371.
16. Kluba-Wojewoda U, Krupa M, Moskala M, Garlicki A, Krukowiecki J, Bociaga-Jasik M et al. Post-traumatic bacterial meningitis. Przegl Lek 2000;57(12):699-701.
17. Kamei S. Bacterial meningitis: determination of pathogens and therapeutic management. Rinsho Shinkeigaku 2004;44:846-848.
18. Zingale A, Ippolito S, Pappalardo P, Chibbaro S, Amoroso R. Infections and re-infections in long-term external ventricular drainage. A variation upon a theme. J Neurosurg Sci 1999;43:125-132.